Penn researchers recently presented findings from the CAR T Cell clinical trial at the American Society of Hematology (ASH) annual meeting.
Connect with a clinical trial navigator who can assist in determining if studies are appropriate for you and/or help find a study for which you may be eligible. If appropriate, the navigator will refer you to the study coordinator.
If you are interested in chronic lymphocytic leukemia or acute lymphoblastic leukemia treatment at Penn, or to schedule an appointment with a cancer physician specializing in immunotherapy call 800-789-PENN (7366) or request an appointment online.
Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors
Researchers at Penn's Abramson Cancer Center have molecularly engineered T-cells from patients with chronic lymphocytic leukemia and re-introduced them with remarkable success.
Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in Penn's Abramson Cancer Center, was named the winner of the 92nd annual Philadelphia Award. Read more...